Childhood overweight continues to increase at an alarming rate and the need exists to find effective, accessible intervention strategies to prevent and treat children who are at risk for being overweight or are already overweight. The primary care setting provides an attractive option for families wishing to receive treatment, yet little is known about the feasibility, acceptance or efficacy of this intervention setting. The purpose of this study was to test two different primary care treatments that were intended to increase fruit and vegetable intake, increase physical activity, and reduce sedentary activity in children ages 4-8, who are overweight or at risk for becoming overweight. Both treatments involved the child and a parent/caregiver and both were conducted over a four month period. The parent/child dyads were selected from the pool of families who receive their primary care within the Geisinger Medical Center geographic area and who have been identified by their pediatrician as being overweight or at risk for becoming overweight (BMI \>85th percentile for age). One group received weekly mailings which focused on healthy eating, promotion of fruit and vegetable intake and physical activity, and methods to reduce TV viewing time. The second group received a group-based intervention at one of the Geisinger Pediatric Clinic sites using specific behavioral strategies for increasing fruit and vegetable intake, reducing TV viewing and encouraging physical activity. Changes in overweight percentage, child BMI, lipid profile, glucose/insulin levels, and anthropometric measurements were analyzed, as well as treatment satisfaction and acceptance. The investigators hypothesized that children who receive Family Behavior Modification (FBM) in the primary care setting will show greater reductions in Body Mass Index (BMI), BMI z-score, percent overweight and waist circumference, and that children receiving FBM will show greater improvements in dietary intake, increased physical activity, reduced sedentary activity, and improvements in cardiovascular outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
51
5-month intervention for parents and children providing 15 sessions in behavioral skills training in self monitoring, Traffic Light Diet, goal setting, reinforcement and tasting sessions. Of the 15 sessions, 3 were structured as phone sessions.
Families assigned to MNI received a series of 15 mailings on topics related identifying a healthy body weight for children; energy balance and calorie requirements for children; MyPyramid for Kids; portion control; the benefits of physical activity and screen-time reduction; encouraging fruit and vegetable consumption; healthy snacks and smart shopping; and encouraging family meals.
University of Pennsylvania Center for Weight and Eating Disorders
Philadelphia, Pennsylvania, United States
Child's Overweight Percentage
Change in child's overweight percentage will be measured from baseline to end of treatment (month 5)
Time frame: Baseline and Month 5
Body Mass Index z-score (BMI-z)
Change in BMI-z score will be measured from baseline to end of treatment (month 5)
Time frame: Baseline and Month 5
Waist Circumference
Change in child's waist circumference will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
Body Mass Index (BMI)
Change in BMI will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
Dietary Intake
Change in dietary intake (kcals, protein, fat, saturated fat, cholesterol, fiber, carbohydrate, fruit/veg servings, Vitamins A and C) will be assessed from baseline to end of treatment (month 5) using 24-hour recall interviews.
Time frame: Baseline and Month 5
Activity Level
Physical activity (sedentary, light, moderate and moderate to vigorous) will be assessed via accelerometry between baseline and end of treatment (month 5).
Time frame: Baseline to Month 5
Insulin (uUnits/ml)
Change in fasting insulin will be measured at baseline and end of treatment (month 5).
Time frame: Baseline and Month 5
Glucose (mg/dl)
Change in fasting glucose levels will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
Triglycerides (mg/dl)
Change in fasting triglyceride levels will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
HDL (mg/dl)
Change in HDL levels will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
LDL (mg/dl)
Change in LDL levels will be measured from baseline to end of treatment (month 5).
Time frame: Baseline and Month 5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.